Abstract: A complex rehabilitation technology system includes a frame and a complex rehabilitation technology device. This frame is movable between a collapsed carriable position and an expanded support position to facilitate portability or storage. The complex rehabilitation technology device is coupled to the frame. And, the complex rehabilitation technology device is configured to be operable when the frame is in the expanded support position. The complex rehabilitation technology system can be portable (e.g., configured for one-handed carrying).

Abstract: A complex rehabilitation technology system includes a frame and a complex rehabilitation technology device. This frame is movable between a collapsed carriable position and an expanded support position to facilitate portability or storage. The complex rehabilitation technology device is coupled to the frame. And, the complex rehabilitation technology device is configured to be operable when the frame is in the expanded support position. The complex rehabilitation system can be portable (e.g., configured for one-handed carrying).

Abstract: The present invention relates to the use of inhibitors of the P2X4 receptor or inhibitors of the P2X4 receptor signaling pathway in combination with an effective amount of a “cell death inducing chemotherapeutic drug” or “cell death inducing therapy” in the prevention and/or treatment of a solid tumor or metastases thereof in a subject, in particular in colorectal cancer (CRC).

Abstract: Methods, systems, and computer program products for using a confidence measure to automatically identify a diagnostic analyzer that applies to a diagnostic artifact. A plurality of diagnostic analyzers are each configured to analyze diagnostic artifacts relating to prior executions of software entities. A confidence measure is calculated for each diagnostic analyzer. Each confidence measure indicates a likelihood that the diagnostic analyzer applies to a particular diagnostic artifact. Calculating each confidence measure comprises applying one or more heuristics specific to the diagnostic analyzer against the particular diagnostic artifact, with an outcome of application of each heuristic contributing to the confidence measure for the respective diagnostic analyzer.

Abstract: A complex rehabilitation technology system includes a frame and a complex rehabilitation technology device. This frame is movable between a collapsed carriable position and an expanded support position to facilitate portability or storage. The complex rehabilitation technology device is coupled to the frame. And, the complex rehabilitation technology device is configured to be operable when the frame is in the expanded support position. The complex rehabilitation technology system can be portable (e.g., configured for one-handed carrying).

Abstract: Methods, systems, and computer program products for using a confidence measure to automatically identify a diagnostic analyzer that applies to a diagnostic artifact. A plurality of diagnostic analyzers are each configured to analyze diagnostic artifacts relating to prior executions of software entities. A confidence measure is calculated for each diagnostic analyzer. Each confidence measure indicates a likelihood that the diagnostic analyzer applies to a particular diagnostic artifact. Calculating each confidence measure comprises applying one or more heuristics specific to the diagnostic analyzer against the particular diagnostic artifact, with an outcome of application of each heuristic contributing to the confidence measure for the respective diagnostic analyzer.

Abstract: A complex rehabilitation technology system includes a frame and a complex rehabilitation technology device. This frame is movable between a collapsed carriable position and an expanded support position to facilitate portability or storage. The complex rehabilitation technology device is coupled to the frame. And, the complex rehabilitation technology device is configured to be operable when the frame is in the expanded support position. The complex rehabilitation system can be portable (e.g., configured for one-handed carrying).

Abstract: Described are systems and techniques for characterizing optical fibers. Disclosed systems and techniques employ optical metrology, functional metrology, or both to characterize microstructured optical fibers and determine fiber characteristics, errors, and quality control metrics. The characteristics, errors, and quality control metrics are useful for improving the manufacturing of optical fibers.

Abstract: Described are systems and techniques for characterizing optical fibers. Disclosed systems and techniques employ optical metrology, functional metrology, or both to characterize microstructured optical fibers and determine fiber characteristics, errors, and quality control metrics. The characteristics, errors, and quality control metrics are useful for improving the manufacturing of optical fibers.

Abstract: An apparatus is disclosed as having, for example, a frame, a support assembly, and a pivot joint pivotably connected to the frame and the support assembly for positioning in a plurality of modes including, for example, a user in supine, standing, and/or prone positions. The apparatus may be positioned within various ranges that include supine and prone modes without re-configuring the apparatus.

Abstract: An apparatus is disclosed as having, for example, a frame, a support assembly, and a pivot joint pivotably connected to the frame and the support assembly for positioning in a plurality of modes including, for example, a user in supine, standing, and/or prone positions. The apparatus may be positioned within various ranges that include supine and prone modes without re-configuring the apparatus.

Abstract: The invention relates to the use of 2-substituted pyrimidines of formula (I), wherein R1, R2, R3, R4 and X have the meanings as defined in the description; for combating nematode diseases of plants, a method for the protection of plants from attack or infestation by nematode pests which comprises applying to the foliage, shoot, root, or seed of the plants, or to the soil or water in which they are, an effective amount of compounds of formula (I).

Abstract: A wireless communications system including a network application server; and a base station to receive an expedited request packet from a subscriber unit by way of a radio frequency interface, attempt to reserve channel resources for a traffic channel to communicate with the subscriber unit, and notify the network application server of whether the channel resources have been reserved. The base station may notify the network application server by marking the expedited request packet received from the subscriber unit, and sending the marked expedited request packet to the network application server.

Abstract: A wireless communications system including a network application server to transmit an expedited request packet; and a base station to receive the expedited request packet from the network application server, attempt to reserve channel resources for a traffic channel to communicate with the SU, and notify the network application server of whether the channel resources have been reserved. The base station may notify the network application server by transmitting the expedited request packet to the SU, receiving a response to the expedited request packet from the SU, marking the response to indicate whether the channel resources have been reserved, and sending the marked response to the network application server.

Abstract: A substantially purified lifeguard (LFG) polypeptide is provided. The polypeptide includes an amino acid sequence as set forth in SEQ ID NO: 2, or a conservative variant thereof. An isolated polynucleotide is provided that encodes an amino acid sequence as set forth in SEQ ID NO: 2, or a conservative variant thereof. An antibody is provided that binds to a polypeptide having an amino acid sequence as set forth in SEQ ID NO: 2. A method is provided for identifying a compound which affects a function of a polypeptide as set forth in SEQ ID NO: 2, or a conservative variant thereof, or affects the expression of a polynucleotide comprising a sequence as set forth in SEQ ID NO: 1. A method is provided for treating a subject with a disorder associated with decreased or increased Fas-mediated cell death. A method is provided for treating a patient having or at risk of having a disorder associated with increased Fas-mediated cell death.

Abstract: A substantially purified lifeguard (LFG) polypeptide is provided. The polypeptide includes an amino acid sequence as set forth in SEQ ID NO:2, or a conservative variant thereof. An isolated polynucleotide is provided that encodes an amino acid sequence as set forth in SEQ ID NO:2, or a conservative variant thereof. An antibody is provided that binds to a polypeptide having an amino acid sequence as set forth in SEQ ID NO:2. A method is provided for identifying a compound which affects a function a polypeptide as set forth in SEQ ID NO:2, or a conservative variant thereof, or affects the expression of a polynucleotide comprising a sequence as set forth in SEQ ID NO:1. A method is provided for treating a subject with a disorder associated with decreased or increased Fas-mediated cell death. A method is provided for treating a patient having or at risk of having a disorder associated with increased Fas-mediated cell death.